Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Galena Biopharma GALE

Healthcare Biotechnology
"Galena Biopharma is a biopharmaceutical company. Its main activity is the development and commercialization of hematology and oncology therapies. Its pipeline includes products targeting hematology diseases, breast cancer, gastric cancer, and gynecological cancer. The company’s cancer immunotherapy consists of two areas: prevention of cancer reoccurrence and primary prevention of invasive... see more

Recent & Breaking News (NDAQ:GALE)

SELLAS Enters into a Clinical Trial Collaboration and Supply Agreement with Merck & Co., Inc., Kenilworth, N.J., USA

PR Newswire Europe Non Regulatory October 2, 2017

Galena Biopharma Announces Completion of Enrollment in Two NeuVax™ (nelipepimut-S) Clinical Trials in Combination with Trastuzumab

GlobeNewswire September 28, 2017

Stock Performance Review on Biotech Industry -- Galena Biopharma, Idera Pharma, Ignyta, and Jaguar Health

PR Newswire September 18, 2017

Galena Biopharma and BioVascular, Inc. Reaffirm GALE-401 Partnership

GlobeNewswire September 11, 2017

Galena Biopharma Reports Second Quarter 2017 Financial Results

GlobeNewswire August 14, 2017

Galena Biopharma Enters into Merger Agreement with SELLAS Life Sciences Group

GlobeNewswire August 8, 2017

Galena Biopharma Provides Corporate Update

GlobeNewswire July 12, 2017

Breakfast Technical Briefing on Biotech Stocks -- CEL-SCI, Amicus Therapeutics, Galena Biopharma, and Cleveland BioLabs

PR Newswire June 12, 2017

Galena Biopharma Reports First Quarter 2017 Financial Results

GlobeNewswire May 10, 2017

DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Galena Biopharma, Inc. (GALE) & Lead Plaintiff Deadline - April 14, 2017

GlobeNewswire April 13, 2017

GALE APRIL 14 ALERT: Rosen Law Firm Reminds Galena Biopharma, Inc. Investors of Important Deadline in Class Action - GALE

PR Newswire April 12, 2017

Research Reports Initiation on Biotech Stocks -- Sarepta Therapeutics, Galena Biopharma, Anthera Pharma, and Clovis Oncology

PR Newswire April 7, 2017

Deadline Alert: GPM Reminds Investors of the April 14 Deadline in the Class Action Lawsuit Against Galena Biopharma, Inc.

Business Wire April 5, 2017

DEADLINE ALERT: Brower Piven Reminds Investors Of The Upcoming Deadline In Class Action Lawsuit And Encourages Investors With Losses In Excess of $100,000 From Investment In Galena Biopharma, Inc. To Contact The Firm

Business Wire April 4, 2017

April 14 Deadline Alert: Law Offices of Howard G. Smith Reminds Galena Biopharma, Inc. Investors of Upcoming Lead Plaintiff Deadline

Business Wire April 4, 2017

Galena Biopharma Presents Positive Interim Safety Data on the NeuVax™ (nelipepimut-S) Clinical Trial in Combination with Trastuzumab in High-Risk HER2 3+ Patients at the AACR Annual Meeting 2017

GlobeNewswire April 4, 2017

INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Galena Biopharma, Inc. and Reminds Investors with Losses in Excess of $100,000 to Contact the Firm

GlobeNewswire April 3, 2017

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Galena Biopharma, Inc. To Contact The Firm

PR Newswire April 3, 2017

INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Galena Biopharma, Inc. and Encourages Investors with Losses Over $100,000 to Contact the Firm

GlobeNewswire March 31, 2017

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Galena Biopharma, Inc. - GALE

PR Newswire March 31, 2017